These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29622803)

  • 1. Simultaneous reprogramming and gene editing of human fibroblasts.
    Howden SE; Thomson JA; Little MH
    Nat Protoc; 2018 May; 13(5):875-898. PubMed ID: 29622803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling.
    Arias-Fuenzalida J; Jarazo J; Qing X; Walter J; Gomez-Giro G; Nickels SL; Zaehres H; Schöler HR; Schwamborn JC
    Stem Cell Reports; 2017 Nov; 9(5):1423-1431. PubMed ID: 28988985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts.
    Howden SE; Maufort JP; Duffin BM; Elefanty AG; Stanley EG; Thomson JA
    Stem Cell Reports; 2015 Dec; 5(6):1109-1118. PubMed ID: 26584543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise and efficient scarless genome editing in stem cells using CORRECT.
    Kwart D; Paquet D; Teo S; Tessier-Lavigne M
    Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 Genome Editing of Human-Induced Pluripotent Stem Cells Followed by Granulocytic Differentiation.
    Dannenmann B; Nasri M; Welte K; Skokowa J
    Methods Mol Biol; 2020; 2115():471-483. PubMed ID: 32006418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Episomal Reprogramming of Human Peripheral Blood Mononuclear Cells into Pluripotency.
    Wen W; Cheng T; Zhang XB
    Methods Mol Biol; 2021; 2239():117-133. PubMed ID: 33226616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.
    Li XL; Li GH; Fu J; Fu YW; Zhang L; Chen W; Arakaki C; Zhang JP; Wen W; Zhao M; Chen WV; Botimer GD; Baylink D; Aranda L; Choi H; Bechar R; Talbot P; Sun CK; Cheng T; Zhang XB
    Nucleic Acids Res; 2018 Nov; 46(19):10195-10215. PubMed ID: 30239926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
    Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
    Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs.
    Li PP; Margolis RL
    Sci Rep; 2021 May; 11(1):9865. PubMed ID: 33972655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated FOXG1 gene editing in human Rett primary cells.
    Croci S; Carriero ML; Capitani K; Daga S; Donati F; Papa FT; Frullanti E; Lopergolo D; Lamacchia V; Tita R; Giliberti A; Benetti E; Niccheri F; Furini S; Lo Rizzo C; Conticello SG; Renieri A; Meloni I
    Eur J Hum Genet; 2020 Oct; 28(10):1446-1458. PubMed ID: 32541681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa.
    Shinkuma S; Guo Z; Christiano AM
    Proc Natl Acad Sci U S A; 2016 May; 113(20):5676-81. PubMed ID: 27143720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
    Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
    Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fast method to reprogram and CRISPR/Cas9 gene editing from erythroblasts.
    Melo US; de Souza Leite F; Costa S; Rosenberg C; Zatz M
    Stem Cell Res; 2018 Aug; 31():52-54. PubMed ID: 30015173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A piggyBac-based platform for genome editing and clonal rhesus macaque iPSC line derivation.
    Rodriguez-Polo I; Mißbach S; Petkov S; Mattern F; Maierhofer A; Grządzielewska I; Tereshchenko Y; Urrutia-Cabrera D; Haaf T; Dressel R; Bartels I; Behr R
    Sci Rep; 2021 Jul; 11(1):15439. PubMed ID: 34326359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Level Precise Knockin of iPSCs by Simultaneous Reprogramming and Genome Editing of Human Peripheral Blood Mononuclear Cells.
    Wen W; Cheng X; Fu Y; Meng F; Zhang JP; Zhang L; Li XL; Yang Z; Xu J; Zhang F; Botimer GD; Yuan W; Sun C; Cheng T; Zhang XB
    Stem Cell Reports; 2018 Jun; 10(6):1821-1834. PubMed ID: 29754960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization.
    Roberts B; Haupt A; Tucker A; Grancharova T; Arakaki J; Fuqua MA; Nelson A; Hookway C; Ludmann SA; Mueller IA; Yang R; Horwitz R; Rafelski SM; Gunawardane RN
    Mol Biol Cell; 2017 Oct; 28(21):2854-2874. PubMed ID: 28814507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts.
    Vosough M; Ravaioli F; Zabulica M; Capri M; Garagnani P; Franceschi C; Piccand J; Kraus MR; Kannisto K; Gramignoli R; Strom SC
    PLoS One; 2019; 14(4):e0215490. PubMed ID: 31022207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rapid Pipeline to Model Rare Neurodevelopmental Disorders with Simultaneous CRISPR/Cas9 Gene Editing.
    Bell S; Peng H; Crapper L; Kolobova I; Maussion G; Vasuta C; Yerko V; Wong TP; Ernst C
    Stem Cells Transl Med; 2017 Mar; 6(3):886-896. PubMed ID: 28170165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.